TransMedics Group, Inc. (TMDX) Earnings History
Profitable10 years of earnings data (2016–2025) · Positive TTM net income
Loading earnings history...
TransMedics Group, Inc. (TMDX) Earnings Overview
As of June 22, 2026, TransMedics Group, Inc. (TMDX) reported trailing twelve-month net income of $172M, reflecting +382.2% year-over-year growth. The company earned $4.75 per diluted share over the past four quarters, with a net profit margin of 31.4%.
Looking at the long-term picture, TMDX's historical earnings data spans multiple years. The company achieved its highest annual net income of $190M in fiscal 2025, representing a new all-time high.
TransMedics Group, Inc. maintains industry-leading profitability with a gross margin of 59.9%, operating margin of 17.9%, and net margin of 31.4%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including AVXL (-$40M net income), STVN ($141M net income, 11.8% margin), NVCR (-$173M net income, -20.8% margin), TMDX has comparable earnings metrics. Compare TMDX vs AVXL →
TMDX Earnings vs Peers
Earnings metrics vs comparable public companies
TMDX Historical Earnings Data (2016–2025)
10 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $190M | +436.6% | $109M | $4.87 | 31.4% | 17.9% |
| 2024 | $35M | +241.7% | $37M | $1.01 | 8.0% | 8.5% |
| 2023 | -$25M | +30.9% | -$29M | $-0.77 | -10.4% | -11.9% |
| 2022 | -$36M | +18.1% | -$31M | $-1.23 | -38.8% | -33.6% |
| 2021 | -$44M | -53.8% | -$39M | $-1.60 | -146.1% | -130.3% |
| 2020 | -$29M | +14.3% | -$26M | $-1.16 | -112.1% | -102.9% |
| 2019 | -$34M | -41.2% | -$30M | $-2.36 | -142.1% | -125.4% |
| 2018 | -$24M | -14.1% | -$20M | $-1.23 | -182.5% | -155.5% |
| 2017 | -$21M | +13.5% | -$20M | $-1.44 | -271.0% | -265.8% |
| 2016 | -$24M | - | -$23M | $-1.66 | -387.6% | -370.2% |
Download Data
Export TMDX earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
10+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
TMDX — Frequently Asked Questions
Quick answers to the most common questions about buying TMDX stock.
What is TMDX earnings per share (EPS)?
TMDX trailing twelve-month (TTM) diluted EPS is $4.75, reflecting +382.2% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2016 to 2025 is available in the table on this page.
What is TransMedics Group, Inc.'s net income?
TransMedics Group, Inc. (TMDX) trailing twelve-month net income is $172M as of 2025. Earnings grew +382.2% year-over-year. TransMedics Group, Inc. has been profitable for 2 consecutive years.
Is TMDX profitable?
Yes, TMDX is profitable with a TTM net income of $172M and a net profit margin of +31.4%. TransMedics Group, Inc. has generated profits for 2 consecutive years.
What is TMDX's earnings growth rate?
TMDX compound annual EPS growth rates (CAGR): 1-Year: +382.2%, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2016 to 2025.
What are TMDX's profit margins?
TransMedics Group, Inc. net profit margin is +31.4%, operating margin is +17.9%, and gross margin is +59.9%. Above-average net margins reflect strong pricing power and competitive moat. Return on Equity is +54.2%.
Is TMDX growing earnings?
Yes, TMDX earnings are accelerating — EPS growth of +382.2% exceeds the 5-year CAGR of N/A. TTM net income reached $172M. Earnings momentum is strengthening.
What was TMDX's best earnings year?
TransMedics Group, Inc.'s highest annual net income on record is $190M, achieved in fiscal year 2025. Earnings history on this page spans 2016 to 2025 and includes all annual and quarterly figures.
What were TMDX's earnings last quarter?
TMDX's most recent reported quarter was Q1 2026. Net income was $7M with diluted EPS of $0.20. For a full breakdown of all quarters, see the quarterly earnings table on this page.